Dexcom (DXCM) EBITDA Margin Growth (1y) (2011 - 2026)
Dexcom (DXCM) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 146.00 |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 54.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 595.00 |
| Mar 31, 2026 | 851.00 |
| Dec 31, 2025 | 868.00 |
| Sep 30, 2025 | 476.00 |
| Jun 30, 2025 | 264.00 |
| Mar 31, 2025 | 193.00 |
| Dec 31, 2024 | -400.00 |
| Sep 30, 2024 | -579.00 |
| Jun 30, 2024 | 103.00 |
| Mar 31, 2024 | 461.00 |
| Dec 31, 2023 | 558.00 |
| Sep 30, 2023 | 191.00 |
| Jun 30, 2023 | 364.00 |
| Mar 31, 2023 | -20.00 |
| Dec 31, 2022 | 1,530.00 |
| Sep 30, 2022 | 97.00 |
| Jun 30, 2022 | -591.00 |
| Mar 31, 2022 | -252.00 |
| Dec 31, 2021 | -1,819.00 |
| Sep 30, 2021 | -59.00 |